Heim, R. Synthesis and pharmacology of potent 5-HT2A receptor agonists with N-2-methoxybenzyl partial structure SC. D. Thesis, Freie Universität, Berlin, 1 Jan 2004. 3.9 MB. #230 In German. MS,NMR,IR
Anon. JW, Personal communication of unpublished research 1 Dec 2011.
Silva, ME; Heim, R; Strasser, A; Elz, S; Dove, S. Theoretical studies on the interaction of partial agonists with the 5-HT2A receptor J. Comput. Aided Mol. Des., 1 Jan 2011, 25 (1), 51–66. 834 kB. https://doi.org/10.1007/s10822-010-9400-2 #20
Silva, ME. Theoretical study of the interaction of agonists with the 5-HT2A receptor Ph. D. Thesis, Universität Regensburg, Regensburg, Germany, 26 Aug 2008. 5.9 MB. #230
Hansen, M. Design and synthesis of selective serotonin receptor agonists for positron emission tomography imaging of the brain Ph. D. Thesis, University of Copenhagen, 16 Dec 2012. 7.9 MB. #2.6, 6.42 NMR
Hyperlab. Hyperlab new compounds 29 Sep 2014. 232 kB. Note: Contains links to hyperlab.info that require elevated access/karma to follow.
Leth-Petersen, S; Gabel-Jensen, C; Gillings, N; Lehel, S; Hansen, HD; Knudsen, GM; Kristensen, JL. Metabolic fate of hallucinogenic NBOMes Chem. Res. Toxicol., 19 Jan 2016, 29 (1), 96–100. 951 kB. https://doi.org/10.1021/acs.chemrestox.5b00450 #4, 16 (SI) See also Supporting information LC,NMR
EMCDDA. New drugs in Europe, 2016, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2017. 489 kB. #32
Hansen, M; Phonekeo, K; Paine, JS; Leth-Petersen, S; Begtrup, M; Bräuner-Osborne, H; Kristensen, JL. Synthesis and structure–activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists ACS Chem. Neurosci., 19 Mar 2014, 5 (3), 243-249. 21.5 MB. https://doi.org/10.1021/cn400216u #2b NMR
Chapman, SJ. Novel Psychoactive Spectra: NMR of (mostly) Novel Psychoactive Substances BLOTTER, 25 Jun 2018, 3 (2). https://doi.org/10.16889/isomerdesign-6 #25B-NBOH NMR
Pertz, HH; Heim, R; Elz, S. N-Benzylated phenylethanamines are highly potent partial agonists at 5-HT2A receptors Arch. Pharm. Pharm. Med. Chem., , 333 (Suppl. 2), 30. 583 kB. #2a-OH Poster abstract
Machado, Y; Neto, JC; Lordeiro, RA; Alves, RB; Piccin, E. Identification of new NBOH drugs in seized blotter papers: 25B-NBOH, 25C-NBOH, and 25E-NBOH Forensic Toxicol., 1 Jan 2020, 38 (1), 203–215. 2.4 MB. https://doi.org/10.1007/s11419-019-00509-7 #25B-NBOH GC,MS,NMR,IR
Poulie, CBM; Jensen, AA; Halberstadt, AL; Kristensen, JL. DARK Classics in Chemical Neuroscience: NBOMes ACS Chem. Neurosci., 2 Dec 2020, 11 (23), 3860-3869. 860 kB. https://doi.org/10.1021/acschemneuro.9b00528 #4
Burgos-Villaseca, J; Klagges-Troncoso, J; Decker, A; Navarro, H; Brea, J; Sáez-Briones, P; Tirapegui, C; Cassels, BK. Caracterización farmacológica in vitro e in vivo del agonista serotoninérgico 5-HT2 superpotente 25B-NBOMe: Modulación de sus efectos inducida por bromación aromática ResearchGate, 1 Jan 2014. 382 kB. https://doi.org/10.13140/2.1.4332.8322 #25B-NB2OH
de Oliveira Magalhães, L; Arantes, LC; Braga, JWB. Identification of NBOMe and NBOH in blotter papers using a handheld NIR spectrometer and chemometric methods Microchem. J., 1 Jan 2019, 144, 151–158. 2.7 MB. https://doi.org/10.1016/j.microc.2018.08.051 #25B-NBOH
Wallach, J; Cao, AB; Calkins, MM; Heim, AJ; Lanham, JK; Bonniwell, EM; Hennessey, JJ; Bock, HA; Anderson, EI; Sherwood, AM; Morris, H; de Klein, R; Klein, AK; Cuccurazzu, B; Gamrat, J; Fannana, T; Zauhar, R; Halberstadt, AL; McCorvy, JD. Identification of 5-HT2A receptor signaling pathways responsible for psychedelic potential bioRxiv, 31 Jul 2023, 2023.07.29.551106. 9.8 MB. https://doi.org/10.1101/2023.07.29.551106 #25B-NBOH LC,MS,NMR